April 24, 2017, 1pm ET
The NIH Microphysiological Systems Program: Tissues-on-chips for Drug Safety and Efficacy Studies
Approximately 30% of drugs fail in human clinical trials due to adverse reactions despite promising pre-clinical studies, and another 60% fail due to lack of efficacy. To address this challenge in drug development, the NIH Tissue-on-Chips program is developing alternative approaches for more reliable readouts of toxicity or efficacy for promising therapeutics. Tissue-on-chips are bioengineered microphysiological systems utilizing chip technology and microfluidics that mimic tissue cytoarchitecture and functional units of human organs. These microfabricated devices are also proving to be useful for modeling human diseases, and for studies in precision medicine and environment exposures.
Please join us for a webinar with Dan Tagle, Associate Director of Special Initiatives for the National Center for Advancing Translational Sciences at the National Institutes of Health to discuss the collaborative mission and structure of the Tissue Chip for Drug Screening Program.
|Meetings and Workshops|| |
Future GUIRR Meeting Dates:June 27-28, 2017
October 17-18, 2017
February 13-14, 2018
June 12-13, 2018
October 16-17, 2018
View past meetings
Have a great topic idea for a GUIRR meeting? Suggest a topic
| || |